We found that the pCR rate of breast cancer patients was significant correlated with ER, PR, HER-2, molecular subsets, tumor size, vascular invasion, nerve invasion, N stage, clinical stage and chemotherapy regimen. This evidence concerns the gene ERBB2 and neoplasm.